To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TCOF1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
510 supporting clones for gene TCOF1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001135243.1   .a 1 to 5095 1 to 5095 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 5095/5095
(100 %)
0 diff
(100 %id)
AK307586   .a 76 to 4461 1 to 4386   tiling clone,   4386/4386
(100 %)
2 diff
(100.0 %id)
AY460334   .a 109 to 4575 1 to 4467 A665P V887A tiling clone,   4467/4467
(100 %)
8 diff
(99.9 %id)
BC008331 Placenta, choriocarcinoma .a 1435 to 4450 1 to 3017   tiling clone, available from MGC, AAA   3017/3017
(100 %)
1 diff
(100.0 %id)
BM542314 melanotic melanoma, skin .a 3592 to 4349 30 to 788       759/1004
(75 %)
23 diff
(97.8 %id)
NM_001135244.1   .b 1 to 4984 1 to 4984 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4984/4984
(100 %)
0 diff
(100 %id)
AK303611 thymus .b 76 to 4354 1 to 4279   tiling clone,   4279/4279
(100 %)
8 diff
(99.9 %id)
AU130168   .b 77 to 818 2 to 743   capped   742/743
(99 %)
6 diff
(99.2 %id)
BG333500 melanotic melanoma, skin .b 79 to 822 1 to 745       745/745
(100 %)
5 diff
(99.4 %id)
CR977306 T-Lymphocytes .b 79 to 841 1 to 766       766/772
(99 %)
3 diff
(99.7 %id)
CN425519 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 85 to 793 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
BU500219   .b 88 to 973 17 to 918       902/964
(93 %)
29 diff
(97.0 %id)
BE893232 melanotic melanoma, skin .b 99 to 881 1 to 786   available from MGC,   786/809
(97 %)
31 diff
(96.2 %id)
BE728121 melanotic melanoma, skin .b 100 to 917 1 to 817       817/1309
(62 %)
22 diff
(98.4 %id)
BM910280 astrocytoma grade IV, cell line, brain .b 104 to 859 7 to 764       758/1063
(71 %)
21 diff
(98.1 %id)
DB293909   .b 104 to 867 2 to 765   capped   764/764
(100 %)
4 diff
(99.5 %id)
BE735261 choriocarcinoma, placenta .b 106 to 957 25 to 867       843/918
(91 %)
30 diff
(96.8 %id)
TI_1948088135   .b 106 to 1124 136 to 1172       1035/1365
(75 %)
58 diff
(95.8 %id)
BM909816 astrocytoma grade IV, cell line, brain .b 111 to 979 22 to 903       882/1114
(79 %)
21 diff
(98.2 %id)
BM810510 astrocytoma grade IV, cell line, brain .b 111 to 987 25 to 916       892/1148
(77 %)
32 diff
(97.3 %id)
BM810021 astrocytoma grade IV, cell line, brain .b 111 to 1107 22 to 1025       1004/1185
(84 %)
30 diff
(97.5 %id)
BG479630 choriocarcinoma, placenta .b 113 to 801 1 to 689       689/691
(99 %)
5 diff
(99.3 %id)
BM018846 astrocytoma grade IV, cell line, brain .b 113 to 942 1 to 821       821/829
(99 %)
25 diff
(97.0 %id)
TI_59389518   .b 114 to 942 104 to 923       820/828
(99 %)
24 diff
(97.2 %id)
BM549968 astrocytoma grade IV, cell line, brain .b 115 to 920 1 to 816       816/1087
(75 %)
12 diff
(98.9 %id)
BQ950623 large cell carcinoma, lung .b 122 to 980 1 to 859       859/864
(99 %)
4 diff
(99.6 %id)
BE280690 choriocarcinoma, placenta .b 133 to 825 1 to 696       696/749
(92 %)
14 diff
(98.2 %id)
BE731127 choriocarcinoma, placenta .b 133 to 936 1 to 801       801/875
(91 %)
21 diff
(97.6 %id)
BE732897 choriocarcinoma, placenta .b 133 to 826 1 to 694       694/697
(99 %)
1 diff
(99.9 %id)
BE732399 choriocarcinoma, placenta .b 133 to 934 1 to 796       796/885
(89 %)
15 diff
(98.4 %id)
BE730849 choriocarcinoma, placenta .b 134 to 984 1 to 841       841/931
(90 %)
17 diff
(98.2 %id)
BQ420611 melanotic melanoma, skin .b 144 to 884 1 to 751       751/911
(82 %)
18 diff
(98.1 %id)
BQ878420 dorsal root ganglia .b 186 to 1073 1 to 890       890/891
(99 %)
4 diff
(99.6 %id)
BU848759 ovary, teratocarcinoma, cell line .b 190 to 1098 1 to 916       916/916
(100 %)
10 diff
(99.0 %id)
BQ226231 embryonal carcinoma, cell line, testis .b 195 to 1073 1 to 882       882/884
(99 %)
4 diff
(99.6 %id)
BM475199 duodenal adenocarcinoma, cell line, small intestine .b 456 to 1322 1 to 882       882/978
(90 %)
21 diff
(97.9 %id)
CN425521 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 470 to 1093 1 to 625       625/625
(100 %)
3 diff
(99.6 %id)
BF204598 muscle, rhabdomyosarcoma .b 489 to 1127 1 to 628       628/860
(73 %)
28 diff
(96.8 %id)
BE893281 melanotic melanoma, skin .b 490 to 1148 50 to 710       661/711
(92 %)
26 diff
(96.4 %id)
DA768579 brain .b 496 to 1058 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BE300153 muscle, rhabdomyosarcoma .b 509 to 1331 1 to 821       821/935
(87 %)
21 diff
(97.8 %id)
BM017690 astrocytoma grade IV, cell line, brain .b 554 to 943 1 to 395       395/656
(60 %)
8 diff
(98.8 %id)
BM019163 astrocytoma grade IV, cell line, brain .b 554 to 1205 1 to 657       657/660
(99 %)
31 diff
(95.4 %id)
BM045077 carcinoma, cell line, Prostate .b 554 to 1146 1 to 598       598/758
(78 %)
15 diff
(98.1 %id)
TI_59388261   .b 555 to 943 64 to 457       394/655
(60 %)
7 diff
(99.0 %id)
TI_59389843   .b 555 to 1205 61 to 716       656/659
(99 %)
30 diff
(95.5 %id)
BE784094 eye, retinoblastoma .b 568 to 1175 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
BG773602 choriocarcinoma, placenta .b 694 to 1109 1 to 420       420/420
(100 %)
12 diff
(97.2 %id)
BU183837 melanotic melanoma, skin .b 743 to 1525 20 to 810       791/902
(87 %)
24 diff
(97.4 %id)
BM556446 duodenal adenocarcinoma, cell line, small intestine .b 786 to 1680 1 to 907       907/1000
(90 %)
15 diff
(98.5 %id)
CB594721 Blood, promyelocytic leukemia .b 796 to 1653 1 to 865       865/880
(98 %)
16 diff
(98.2 %id)
BE313196 brain, neuroblastoma .b 889 to 1604 1 to 710       710/753
(94 %)
27 diff
(96.5 %id)
BQ232717 melanotic melanoma, skin .b 897 to 1739 12 to 859       848/862
(98 %)
26 diff
(97.0 %id)
BU855323 ovary, teratocarcinoma, cell line .b 919 to 1686 1 to 782       782/839
(93 %)
11 diff
(98.7 %id)
DB293343   .b 928 to 1677 2 to 751   capped   750/750
(100 %)
15 diff
(98.0 %id)
AK299167   .b 1044 to 4350 1 to 3307   tiling clone,   3307/3307
(100 %)
2 diff
(100.0 %id)
TI_1948088136   .b 2001 to 2968 1114 to 139       976/1294
(75 %)
44 diff
(96.6 %id)
BM453838 melanotic melanoma, skin .b 2525 to 3380 13 to 870       858/903
(95 %)
16 diff
(98.3 %id)
BG821310 adenocarcinoma cell line, colon .b 2624 to 3359 1 to 738       738/738
(100 %)
8 diff
(99.0 %id)
BU156635 eye, retinoblastoma .b 2639 to 3468 1 to 831       831/886
(93 %)
9 diff
(99.0 %id)
BG116381 duodenal adenocarcinoma, cell line, small intestine .b 2732 to 3513 1 to 782       782/791
(98 %)
20 diff
(97.5 %id)
BF805204 colon_ins .b 3051 to 3561 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
BI029116 marrow .b 3064 to 3576 1 to 513       513/513
(100 %)
5 diff
(99.1 %id)
BQ214315 large cell carcinoma, lung .b 3227 to 3871 9 to 657       649/883
(73 %)
16 diff
(98.2 %id)
DB383279   .b 3777 to 4340 572 to 11       562/575
(97 %)
0 diff
(100 %id)
AU152179   .b 3814 to 4340 538 to 15       524/539
(97 %)
0 diff
(100 %id)
DB383853   .b 3995 to 4340 357 to 11       347/360
(96 %)
0 diff
(100 %id)
NM_001008656.2   .c 1 to 4981 1 to 4981 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4981/4981
(100 %)
0 diff
(100 %id)
BC016144 Skin, melanotic melanoma. .c 81 to 4350 1 to 4270   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 4270/4272
(99 %)
4 diff
(100.0 %id)
BG251064 adenocarcinoma, cell line, Liver .c 3195 to 3956 1 to 758       756/1107
(68 %)
20 diff
(98.2 %id)
NM_001135245.1   .d 1 to 4867 1 to 4867 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4867/4867
(100 %)
0 diff
(100 %id)
DC377932 brain .d 1 to 552 1 to 556   tiling clone,   556/556
(100 %)
6 diff
(99.0 %id)
BP213475 cerebrum .d 28 to 595 1 to 568       568/568
(100 %)
0 diff
(100 %id)
DC324939 brain .d 29 to 603 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BM834587 stomach .d 35 to 628 1 to 594   tiling clone,   594/594
(100 %)
0 diff
(100 %id)
DB135256 thymus .d 45 to 594 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BP232229 muscle .d 49 to 487 1 to 439       439/583
(75 %)
6 diff
(99.0 %id)
BP282977 bone marrow .d 49 to 629 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DB068966 testis .d 50 to 580 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
AU143538   .d 50 to 756 2 to 707   capped   706/775
(91 %)
12 diff
(98.5 %id)
DA742433   .d 53 to 631 2 to 583   capped   582/582
(100 %)
3 diff
(99.5 %id)
DA324422 hippocampus .d 58 to 600 2 to 544   capped   543/543
(100 %)
4 diff
(99.3 %id)
DA320478 hippocampus .d 60 to 550 2 to 492   capped   491/491
(100 %)
5 diff
(99.0 %id)
BP203133 coronary artery .d 61 to 648 1 to 588       588/588
(100 %)
8 diff
(98.7 %id)
BP233312 muscle .d 62 to 642 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
DA220041 brain .d 63 to 600 2 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
BP286623 lung .d 63 to 644 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA755383   .d 63 to 617 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA859606 placenta .d 63 to 598 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB162318 thymus .d 63 to 632 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DB224581 trachea .d 63 to 615 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA509624 brain .d 64 to 635 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DB224133 trachea .d 64 to 641 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA128433 cerebellum .d 65 to 655 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
BM835081 stomach .d 66 to 525 1 to 460       460/460
(100 %)
0 diff
(100 %id)
DA124917 cerebellum .d 67 to 627 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA216095 brain .d 67 to 614 2 to 549   capped   548/550
(99 %)
2 diff
(99.7 %id)
DA312448 hippocampus .d 67 to 612 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA314880 hippocampus .d 67 to 588 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA851258 placenta .d 67 to 633 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA192884 amygdala .d 68 to 664 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA409096 thalamus .d 69 to 638 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BP237778 Liver .d 76 to 674 1 to 599       599/603
(99 %)
4 diff
(99.4 %id)
DA742895   .d 76 to 624 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
BP353847   .d 76 to 659 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP355691   .d 76 to 657 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC410568 thymus .d 76 to 664 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
DB290650 uterus .d 76 to 673 2 to 602   capped   601/601
(100 %)
5 diff
(99.2 %id)
DA187932 amygdala .d 77 to 634 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA215876 brain .d 77 to 580 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DA313348 hippocampus .d 77 to 635 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA386008 thalamus .d 77 to 632 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA438983 tongue, tumor tissue .d 77 to 657 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
AU130374   .d 77 to 787 2 to 712   capped   711/712
(99 %)
5 diff
(99.3 %id)
DA757280   .d 77 to 622 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA798931 brain .d 77 to 613 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA800831 brain .d 77 to 628 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA852117 placenta .d 77 to 609 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB073801 testis .d 77 to 633 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB097341 testis .d 77 to 658 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
CR976039 T-Lymphocytes .d 79 to 706 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
DB452002 testis .d 80 to 580 1 to 501       501/501
(100 %)
4 diff
(99.3 %id)
BP310121 brain .d 80 to 661 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA790936 brain .d 81 to 553 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
CN425517 embryonic stem cells, cell lines H1, H7, andH9 .d 82 to 737 1 to 656       656/656
(100 %)
1 diff
(99.9 %id)
DB004245 breast, tumor tissue .d 83 to 629 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN425516 embryonic stem cells, cell lines H1, H7, andH9 .d 85 to 700 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
DA482584   .d 85 to 656 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA759071   .d 85 to 628 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA690115   .d 93 to 636 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
AL705228 human skeletal muscle .d 101 to 629 1 to 529       529/529
(100 %)
0 diff
(100 %id)
CV028224 mixed .d 109 to 682 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
BM552342 astrocytoma grade IV, cell line, brain .d 115 to 611 1 to 508       508/877
(57 %)
11 diff
(98.8 %id)
BM552642 astrocytoma grade IV, cell line, brain .d 115 to 745 1 to 641       641/1012
(63 %)
15 diff
(98.6 %id)
CN425518 embryonic stem cells, cell lines H1, H7, andH9 .d 144 to 732 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
DA434190 tongue, tumor tissue .d 145 to 629 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
BQ221860 melanotic melanoma, skin .d 147 to 651 1 to 512       512/997
(51 %)
21 diff
(97.9 %id)
BC027252 Eye, retinoblastoma .d 153 to 3532 1 to 3380   tiling clone, available from MGC,   3380/3380
(100 %)
0 diff
(100 %id)
DA183466 amygdala .d 154 to 621 2 to 471   capped   470/470
(100 %)
2 diff
(99.6 %id)
BG954669 colon .d 226 to 484 10 to 267       258/267
(96 %)
2 diff
(99.3 %id)
CX761356 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 297 to 901 1 to 603     Submitted on the opposite strand 603/741
(81 %)
29 diff
(96.1 %id)
CN425515 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 794 to 1427 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
AU131368   .d 814 to 1519 2 to 709   capped   708/710
(99 %)
7 diff
(99.1 %id)
DB239748 trachea .d 859 to 1445 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
AL120715 melanoma (MeWo cell line) .d 869 to 1412 1 to 544       544/544
(100 %)
0 diff
(100 %id)
CR997429 T-Lymphocytes .d 905 to 1512 1 to 608       608/618
(98 %)
1 diff
(99.9 %id)
BF842044 head_neck .d 977 to 1461 11 to 494       484/494
(97 %)
9 diff
(98.2 %id)
TI_154161311   .d 1022 to 1587 66 to 631       566/571
(99 %)
8 diff
(98.6 %id)
BI000653 head_normal .d 1061 to 1714 670 to 22       649/673
(96 %)
8 diff
(98.9 %id)
BM172164 choriocarcinoma, placenta .d 1127 to 1834 1 to 703       703/703
(100 %)
15 diff
(97.9 %id)
BU164785 eye, retinoblastoma .d 1132 to 1966 1 to 855       855/878
(97 %)
27 diff
(97.0 %id)
DA991919 synovial membrane tissue from rheumatioidarthritis .d 1161 to 1621 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
BE272790 Kidney, renal cell adenocarcinoma .d 1166 to 1826 1 to 670       670/674
(99 %)
23 diff
(96.6 %id)
DA714985   .d 1167 to 1707 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB136762 thymus .d 1184 to 1604 2 to 422   capped   421/421
(100 %)
1 diff
(99.8 %id)
CR980115 T-Lymphocytes .d 1231 to 1947 1 to 720       720/720
(100 %)
4 diff
(99.5 %id)
AW249414 lung, small cell carcinoma .d 1236 to 1661 1 to 426       426/426
(100 %)
6 diff
(98.6 %id)
BF968947 adrenal cortex carcinoma, cell line, adrenal gland .d 1287 to 1982 11 to 713       703/1071
(65 %)
18 diff
(98.4 %id)
BG281562 melanotic melanoma, skin .d 1292 to 1960 1 to 711       711/711
(100 %)
61 diff
(91.5 %id)
BM802111 duodenal adenocarcinoma, cell line, small intestine .d 1293 to 1944 28 to 686       659/1064
(61 %)
34 diff
(96.9 %id)
BE388552 endometrium, adenocarcinoma cell line, uterus .d 1312 to 1912 1 to 624       624/624
(100 %)
38 diff
(94.0 %id)
CR996376 T-Lymphocytes .d 1338 to 2066 1 to 733       733/742
(98 %)
4 diff
(99.5 %id)
CD608234   .d 1343 to 1943 18 to 618       601/618
(97 %)
6 diff
(99.1 %id)
CR979267 T-Lymphocytes .d 1356 to 2113 1 to 758       758/758
(100 %)
3 diff
(99.7 %id)
BY796730 eye .d 1377 to 1968 1 to 592       592/592
(100 %)
0 diff
(100 %id)
CN426223 embryonic stem cells, DMSO-treated H9 cellline .d 1379 to 1967 1 to 589       589/589
(100 %)
0 diff
(100 %id)
CD608235   .d 1421 to 2285 865 to 1       865/865
(100 %)
8 diff
(99.1 %id)
BG480714 choriocarcinoma, placenta .d 1442 to 2149 1 to 719       719/729
(98 %)
10 diff
(98.7 %id)
BI117289 lung, small cell carcinoma .d 1485 to 2146 1 to 673       673/714
(94 %)
12 diff
(98.4 %id)
BP240986 Liver .d 1497 to 2073 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
CR976713 T-Lymphocytes .d 1504 to 2325 1 to 830       830/832
(99 %)
16 diff
(98.1 %id)
BU188744 melanotic melanoma, skin .d 1511 to 2327 12 to 834       823/869
(94 %)
16 diff
(98.2 %id)
BI197296 brain, neuroblastoma .d 1516 to 2220 1 to 710       710/734
(96 %)
19 diff
(97.5 %id)
BG899285 cartilage .d 1530 to 1877 86 to 433       348/365
(95 %)
9 diff
(97.6 %id)
BG899286 cartilage .d 1530 to 1875 81 to 426       346/363
(95 %)
17 diff
(95.4 %id)
BE313405 brain, neuroblastoma .d 1536 to 2214 1 to 681       681/764
(89 %)
21 diff
(97.3 %id)
BE261096 brain, neuroblastoma .d 1536 to 2207 1 to 671       671/758
(88 %)
11 diff
(98.6 %id)
BE618508 eye, retinoblastoma .d 1536 to 2210 1 to 677       677/678
(99 %)
5 diff
(99.3 %id)
AW499717 lymph .d 1537 to 1840 1 to 304       304/304
(100 %)
10 diff
(96.8 %id)
CF135407 lymph .d 1537 to 2007 1 to 470       470/470
(100 %)
8 diff
(98.3 %id)
BE891211 melanotic melanoma, skin .d 1538 to 2224 1 to 703       703/946
(74 %)
20 diff
(97.9 %id)
BG488565 large cell carcinoma, lung .d 1588 to 2255 1 to 668       668/669
(99 %)
6 diff
(99.2 %id)
CN426220 embryonic stem cells, cell lines H1, H7, andH9 .d 1709 to 2405 1 to 698       698/698
(100 %)
2 diff
(99.8 %id)
CA487251   .d 1766 to 2419 1 to 655       655/737
(88 %)
2 diff
(99.8 %id)
CR977016 T-Lymphocytes .d 1777 to 2672 1 to 900       900/902
(99 %)
12 diff
(98.7 %id)
DA200765 brain .d 1780 to 2320 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
CN426217 embryonic stem cells, cell lines H1, H7, andH9 .d 1782 to 2477 1 to 695       695/695
(100 %)
1 diff
(99.9 %id)
CN426216 embryonic stem cells, cell lines H1, H7, andH9 .d 1810 to 2338 1 to 528       528/528
(100 %)
4 diff
(99.3 %id)
BM019508 astrocytoma grade IV, cell line, brain .d 1846 to 2538 1 to 705       670/899
(74 %)
31 diff
(96.6 %id)
TI_59390195   .d 1848 to 2538 116 to 818   AAA   668/994
(67 %)
31 diff
(96.9 %id)
BG828324 muscle, rhabdomyosarcoma .d 1888 to 2736 1 to 852       852/1048
(81 %)
39 diff
(96.3 %id)
BE298877 muscle, rhabdomyosarcoma .d 1908 to 2539 1 to 635       635/763
(83 %)
5 diff
(99.4 %id)
BE387597 melanotic melanoma, skin .d 1915 to 2246 49 to 377       329/381
(86 %)
12 diff
(96.9 %id)
BG475658 melanotic melanoma, skin .d 1926 to 2539 17 to 633       617/711
(86 %)
10 diff
(98.6 %id)
AL710825 human skeletal muscle .d 1929 to 2569 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BE274131 melanotic melanoma, skin .d 1933 to 2609 1 to 679       679/713
(95 %)
13 diff
(98.2 %id)
BF125339 melanotic melanoma, skin .d 1933 to 2585 1 to 653       653/974
(67 %)
16 diff
(98.4 %id)
DA872157 Prostate .d 1948 to 2527 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BE798000 lung, small cell carcinoma .d 1951 to 2681 33 to 770       738/779
(94 %)
39 diff
(95.0 %id)
BM793109 Ascites, stomach .d 1966 to 2436 1 to 471       471/471
(100 %)
5 diff
(99.0 %id)
BG574196 breast, mammary adenocarcinoma, cell line .d 1982 to 2693 1 to 710       710/710
(100 %)
5 diff
(99.3 %id)
BJ990014 hepatoblastoma .d 2001 to 2586 15 to 600       586/600
(97 %)
6 diff
(99.0 %id)
CN426222 embryonic stem cells, DMSO-treated H9 cellline .d 2002 to 2312 1 to 311       311/311
(100 %)
0 diff
(100 %id)
BQ226044 melanotic melanoma, skin .d 2034 to 2676 11 to 663       653/999
(65 %)
17 diff
(98.3 %id)
BG823310 adenocarcinoma cell line, colon .d 2045 to 2800 1 to 756       756/921
(82 %)
23 diff
(97.6 %id)
BM542392 melanotic melanoma, skin .d 2048 to 2637 1 to 596       596/1057
(56 %)
30 diff
(97.2 %id)
AI904492 breast .d 2112 to 2266 155 to 1       155/155
(100 %)
1 diff
(99.4 %id)
BU159478 eye, retinoblastoma .d 2142 to 2921 1 to 789       789/863
(91 %)
8 diff
(99.1 %id)
AU125437   .d 2172 to 2888 2 to 719   capped   718/718
(100 %)
3 diff
(99.6 %id)
BP245873 Kidney .d 2177 to 2758 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DB248043 uterus .d 2188 to 2707 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
BG393408 embryonal carcinoma, cell line, testis .d 2207 to 2988 1 to 781       781/808
(96 %)
20 diff
(97.6 %id)
AU136802 placenta .d 2281 to 2986 2 to 718   capped   717/720
(99 %)
10 diff
(98.7 %id)
BE275600 melanotic melanoma, skin .d 2295 to 2780 1 to 488       488/488
(100 %)
6 diff
(98.8 %id)
BG750853 eye, normal pigmented retinal epithelium .d 2326 to 3125 1 to 797       797/797
(100 %)
5 diff
(99.4 %id)
AW579511 head_neck .d 2436 to 3046 8 to 619       612/647
(94 %)
22 diff
(96.6 %id)
BU162209 leiomyosarcoma, uterus .d 2437 to 3032 1 to 601       601/771
(77 %)
7 diff
(99.1 %id)
BM911494 amelanotic melanoma, cell line, skin .d 2459 to 3395 1 to 941       941/1099
(85 %)
15 diff
(98.7 %id)
BE728897 melanotic melanoma, skin .d 2480 to 3216 1 to 736       736/739
(99 %)
7 diff
(99.1 %id)
BE728588 melanotic melanoma, skin .d 2481 to 3214 1 to 739       739/740
(99 %)
15 diff
(98.0 %id)
BE729641 melanotic melanoma, skin .d 2481 to 3295 1 to 800       800/934
(85 %)
60 diff
(93.6 %id)
BE792061 lung, small cell carcinoma .d 2494 to 3308 1 to 813       813/992
(81 %)
12 diff
(98.8 %id)
BG328554 adenocarcinoma cell line, colon .d 2498 to 3120 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
BE793163 lung, small cell carcinoma .d 2532 to 3262 1 to 731       731/732
(99 %)
2 diff
(99.8 %id)
EC510949 Prostate .d 2579 to 2684 104 to 1       104/104
(100 %)
2 diff
(98.1 %id)
CD654855 Embryonic Stem cells .d 2770 to 3566 1 to 789       789/830
(95 %)
16 diff
(98.1 %id)
CD643248 Embryonic Stem cells .d 2770 to 3535 1 to 762       762/763
(99 %)
5 diff
(99.4 %id)
BM564021 blood, natural killer cells, cell line .d 2782 to 3486 1 to 706       706/1255
(56 %)
12 diff
(99.1 %id)
BQ052970 blood, natural killer cells, cell line .d 2783 to 3769 1 to 1008       1008/1068
(94 %)
52 diff
(95.2 %id)
AL519784 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 2789 to 3511 1 to 723   fully sequenced,   723/723
(100 %)
2 diff
(99.8 %id)
EC564194 Prostate .d 2795 to 2893 98 to 1       98/98
(100 %)
1 diff
(99.0 %id)
AW370426 breast .d 2821 to 3150 1 to 331       331/331
(100 %)
11 diff
(96.7 %id)
BE793399 lung, small cell carcinoma .d 2858 to 3632 1 to 769       769/769
(100 %)
10 diff
(98.7 %id)
BE538511 cervix .d 3006 to 3309 1 to 305       305/353
(86 %)
2 diff
(99.5 %id)
AW609049 pnet .d 3023 to 3556 24 to 556       533/556
(95 %)
17 diff
(97.0 %id)
BQ680644 melanotic melanoma, cell line, skin .d 3036 to 3871 1 to 842       842/940
(89 %)
23 diff
(97.6 %id)
BM013129 brain, neuroblastoma, cell line .d 3045 to 3888 1 to 841       841/855
(98 %)
26 diff
(97.0 %id)
TI_59382379   .d 3045 to 3888 92 to 932       841/855
(98 %)
26 diff
(97.0 %id)
T95218 liver and spleen .d 3070 to 3371 1 to 301       301/318
(94 %)
4 diff
(98.8 %id)
BM852328 Ascites, stomach .d 3075 to 3585 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BQ637879 eye, retina .d 3076 to 3655 1 to 580       580/580
(100 %)
0 diff
(100 %id)
CN426221 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 3094 to 3822 1 to 730       730/730
(100 %)
3 diff
(99.6 %id)
BF805549 colon_ins .d 3104 to 3517 1 to 411       411/411
(100 %)
6 diff
(98.6 %id)
CN426214 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 3152 to 3669 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
AW806508 stomach .d 3322 to 3748 1 to 422       422/422
(100 %)
8 diff
(98.2 %id)
BQ052523 blood, natural killer cells, cell line .d 3329 to 4212 1 to 899       899/1033
(87 %)
26 diff
(97.5 %id)
BM802904 duodenal adenocarcinoma, cell line, small intestine .d 3334 to 4005 1 to 677       677/1189
(56 %)
4 diff
(99.7 %id)
BQ920719 carcinoma, cell line, Prostate .d 3349 to 4216 1 to 868       868/950
(91 %)
12 diff
(98.8 %id)
BM713047 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 3352 to 3694 1 to 343       343/343
(100 %)
0 diff
(100 %id)
BM716928 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 3352 to 4056 1 to 702       702/703
(99 %)
6 diff
(99.2 %id)
BQ221320 embryonal carcinoma, cell line, testis .d 3400 to 4165 1 to 771       771/923
(83 %)
13 diff
(98.6 %id)
AL519783 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 3450 to 4179 732 to 7   fully sequenced,   726/732
(99 %)
5 diff
(99.4 %id)
BM802921 duodenal adenocarcinoma, cell line, small intestine .d 3485 to 4325 8 to 848   tiling clone,   841/1045
(80 %)
15 diff
(98.6 %id)
BQ775024 Bone, Human Chondrosarcoma Cell Line .d 3513 to 4223 734 to 27       708/734
(96 %)
1 diff
(99.9 %id)
AW167713 cervix .d 3514 to 4223 718 to 10       711/718
(99 %)
11 diff
(98.5 %id)
BF791898 adrenal cortex carcinoma, cell line, adrenal gland .d 3535 to 4223 1 to 689       689/715
(96 %)
8 diff
(98.9 %id)
AW378565 head_neck .d 3566 to 4219 1 to 649       649/695
(93 %)
21 diff
(97.0 %id)
BM995640 Chondrosarcoma, Left Pubic Bone .d 3591 to 4222 658 to 29   AAA   630/640
(98 %)
4 diff
(99.4 %id)
CD742914 Alveolar Macrophage, lung .d 3592 to 4223 660 to 29       632/660
(95 %)
2 diff
(99.7 %id)
BU738511 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 3594 to 4223 658 to 29       630/658
(95 %)
0 diff
(100 %id)
BM797715 Ascites, stomach .d 3614 to 3967 1 to 355       355/355
(100 %)
4 diff
(98.9 %id)
AI955085 pooled germ cell tumors .d 3619 to 4242 622 to 1       622/623
(99 %)
4 diff
(99.4 %id)
AW779824 Kidney .d 3619 to 4241 621 to 1       621/621
(100 %)
10 diff
(98.4 %id)
BJ990015 hepatoblastoma .d 3669 to 4208 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB367577   .d 3677 to 4223 561 to 11       551/570
(96 %)
0 diff
(100 %id)
AI199923 lung .d 3687 to 4243 549 to 1       549/554
(99 %)
18 diff
(96.8 %id)
AI984038 adenocarcinoma, Pancreas .d 3692 to 4223 539 to 8       532/564
(94 %)
0 diff
(100 %id)
AU153113   .d 3694 to 4223 541 to 11       531/541
(98 %)
0 diff
(100 %id)
AU156874 placenta .d 3701 to 4223 546 to 15       532/555
(95 %)
0 diff
(100 %id)
AI061426   .d 3704 to 4218 515 to 1       515/522
(98 %)
1 diff
(99.9 %id)
AI589808 anaplastic oligodendroglioma, brain .d 3706 to 4302 594 to 1       594/594
(100 %)
12 diff
(98.0 %id)
AI283260 adenocarcinoma, colon .d 3729 to 4223 497 to 3       495/501
(98 %)
0 diff
(100 %id)
CA444040 Fibrosarcoma .d 3730 to 4223 520 to 29       492/520
(94 %)
0 diff
(100 %id)
AW074124 2 pooled high-grade transitional celltumors, genitourinary tract .d 3732 to 4223 504 to 14       491/507
(96 %)
0 diff
(100 %id)
AW451058   .d 3746 to 4223 507 to 28       480/510
(94 %)
0 diff
(100 %id)
DB384740   .d 3752 to 4305 559 to 1       559/562
(99 %)
25 diff
(95.6 %id)
AU149102   .d 3756 to 4305 559 to 1       559/564
(99 %)
17 diff
(97.0 %id)
AW082747 esophagus, squamous cell carcinoma .d 3764 to 4218 453 to 1       453/520
(87 %)
11 diff
(97.9 %id)
DB517534 testis .d 3772 to 4237 1 to 469     Submitted on the opposite strand 469/469
(100 %)
5 diff
(99.0 %id)
AA775939   .d 3781 to 4126 343 to 1       343/343
(100 %)
11 diff
(96.8 %id)
BG056581 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .d 3810 to 4239 429 to 1       429/429
(100 %)
2 diff
(99.6 %id)
BF063392 colon, colon tumor, RER+ .d 3818 to 4241 424 to 1       424/469
(90 %)
1 diff
(99.8 %id)
AA581586 bulk germ cell seminoma .d 3832 to 4238 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AI033443 liver and spleen .d 3832 to 4305 475 to 1       475/475
(100 %)
9 diff
(98.2 %id)
AI248648 liver and spleen .d 3858 to 4309 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
AL133039 testis .d 3864 to 4867 11 to 1013   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1003/1013
(99 %)
7 diff
(99.4 %id)
AW250018.
matches multiple genes
lung, small cell carcinoma .d 3875 to 4302 438 to 11   AAA also hits gene ESRRA 428/428
(100 %)
2 diff
(99.6 %id)
AW074530 colon, juvenile granulosa tumor .d 3886 to 4237 352 to 1       352/352
(100 %)
4 diff
(98.9 %id)
AI880191 astrocytoma, brain .d 3891 to 4188 298 to 1       298/300
(99 %)
0 diff
(100 %id)
AI281701 esophagus, squamous cell carcinoma .d 3897 to 4238 343 to 1       343/396
(86 %)
11 diff
(97.3 %id)
AA770401   .d 3916 to 4242 327 to 1       327/327
(100 %)
1 diff
(99.7 %id)
W93015 liver and spleen .d 3926 to 4300 374 to 1       374/375
(99 %)
1 diff
(99.8 %id)
BU179409 epithelioid carcinoma, Pancreas .d 3995 to 4852 24 to 893       870/895
(97 %)
36 diff
(96.0 %id)
AA094332   .d 4017 to 4216 5 to 202       198/218
(90 %)
6 diff
(97.3 %id)
BE541568 cervix .d 4018 to 4220 1 to 203       203/218
(93 %)
5 diff
(97.8 %id)
BQ427577 eye, retinoblastoma .d 4025 to 4714 21 to 714       694/915
(75 %)
12 diff
(98.7 %id)
AW303086 invasive adenocarcinoma, lung .d 4032 to 4300 35 to 304   AAA Submitted on the opposite strand 270/304
(88 %)
7 diff
(97.7 %id)
BQ218917 leiomyosarcoma, uterus .d 4045 to 4856 1 to 818       818/1008
(81 %)
11 diff
(99.0 %id)
BM905090 melanotic melanoma, skin .d 4055 to 4223 11 to 179       169/205
(82 %)
1 diff
(99.6 %id)
BF768963 epid_tumor .d 4056 to 4352 1 to 297       297/310
(95 %)
1 diff
(99.7 %id)
BF768782 epid_tumor .d 4072 to 4413 6 to 348       341/363
(93 %)
7 diff
(98.1 %id)
BF800727 colon_ins .d 4083 to 4454 10 to 378       369/378
(97 %)
11 diff
(97.1 %id)
AI251259 ovary, papillary serous carcinoma .d 4121 to 4298 2 to 180   AAA Submitted on the opposite strand 179/182
(98 %)
8 diff
(95.7 %id)
AI610035 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .d 4121 to 4530 13 to 424     Submitted on the opposite strand 412/424
(97 %)
7 diff
(98.4 %id)
BF810675 colon_ins .d 4124 to 4294 13 to 183       171/183
(93 %)
6 diff
(96.8 %id)
AW268942 invasive adenocarcinoma, lung .d 4128 to 4204 7 to 82     Submitted on the opposite strand 76/82
(92 %)
6 diff
(92.7 %id)
BG031476 breast, mammary adenocarcinoma, cell line .d 4131 to 4740 1 to 614       612/966
(63 %)
40 diff
(95.9 %id)
AW305329 invasive adenocarcinoma, lung .d 4141 to 4313 19 to 191     Submitted on the opposite strand 173/193
(89 %)
14 diff
(92.8 %id)
AW301744 invasive adenocarcinoma, lung .d 4141 to 4301 8 to 169   AAA Submitted on the opposite strand 162/170
(95 %)
11 diff
(93.6 %id)
AW268069 invasive adenocarcinoma, lung .d 4141 to 4298 1 to 158   AAA Submitted on the opposite strand 158/160
(98 %)
3 diff
(98.2 %id)
TI_154121661   .d 4142 to 4851 784 to 81   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 704/949
(74 %)
13 diff
(98.7 %id)
AV740601 cord Blood .d 4144 to 4316 34 to 203       170/203
(83 %)
10 diff
(95.1 %id)
CR748269 borderline ovarian carcinoma, ovary .d 4144 to 4317 18 to 191       174/191
(91 %)
12 diff
(93.8 %id)
AI054141 ovary, papillary serous carcinoma .d 4144 to 4300 179 to 22   AAA   158/174
(90 %)
3 diff
(98.3 %id)
AI054114 ovary, papillary serous carcinoma .d 4144 to 4316 173 to 1       173/192
(90 %)
6 diff
(96.9 %id)
AI053645 ovary, papillary serous carcinoma .d 4144 to 4300 170 to 14   AAA   157/176
(89 %)
0 diff
(100 %id)
AI053647 ovary, papillary serous carcinoma .d 4144 to 4300 177 to 20   AAA   158/177
(89 %)
2 diff
(98.9 %id)
AI053651 ovary, papillary serous carcinoma .d 4144 to 4300 170 to 14   AAA   157/176
(89 %)
1 diff
(99.5 %id)
AI053768 ovary, papillary serous carcinoma .d 4144 to 4300 171 to 13   AAA   159/178
(89 %)
4 diff
(97.8 %id)
AI054226 ovary, papillary serous carcinoma .d 4144 to 4320 175 to 1       175/191
(91 %)
7 diff
(96.4 %id)
AI053410 ovary, papillary serous carcinoma .d 4144 to 4320 176 to 1       176/195
(90 %)
8 diff
(95.9 %id)
AI266079 lung .d 4144 to 4301 19 to 177   AAA Submitted on the opposite strand 159/178
(89 %)
8 diff
(95.6 %id)
AI284610 breast, invasive carcinoma .d 4144 to 4302 11 to 170   AAA   160/170
(94 %)
7 diff
(95.9 %id)
AI284617 breast, invasive carcinoma .d 4144 to 4324 11 to 190       180/199
(90 %)
15 diff
(92.5 %id)
AI252442 ovary, papillary serous carcinoma .d 4144 to 4299 11 to 165   AAA Submitted on the opposite strand 155/166
(93 %)
8 diff
(95.2 %id)
AI252171 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI255080 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/168
(94 %)
8 diff
(95.3 %id)
AI255089 ovary, papillary serous carcinoma .d 4144 to 4313 11 to 180   AAA Submitted on the opposite strand 170/182
(93 %)
16 diff
(91.3 %id)
AI255090 ovary, papillary serous carcinoma .d 4144 to 4300 31 to 188   AAA Submitted on the opposite strand 158/188
(84 %)
7 diff
(96.3 %id)
AI254810 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
7 diff
(95.9 %id)
AI254051 ovary, papillary serous carcinoma .d 4144 to 4269 22 to 147     Submitted on the opposite strand 126/156
(80 %)
7 diff
(95.6 %id)
AI251276 ovary, papillary serous carcinoma .d 4144 to 4298 11 to 166   AAA Submitted on the opposite strand 156/168
(92 %)
10 diff
(94.1 %id)
AI251214 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/168
(94 %)
7 diff
(95.9 %id)
AI251223 ovary, papillary serous carcinoma .d 4144 to 4319 11 to 183     Submitted on the opposite strand 173/194
(89 %)
12 diff
(93.9 %id)
AI252180 ovary, papillary serous carcinoma .d 4144 to 4302 11 to 170   AAA Submitted on the opposite strand 160/170
(94 %)
7 diff
(95.9 %id)
AI255005 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI254511 ovary, papillary serous carcinoma .d 4144 to 4300 22 to 179   AAA Submitted on the opposite strand 158/179
(88 %)
7 diff
(96.1 %id)
AI254569 ovary, papillary serous carcinoma .d 4144 to 4313 11 to 180   AAA Submitted on the opposite strand 170/183
(92 %)
12 diff
(93.5 %id)
AI254104 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI255023 ovary, papillary serous carcinoma .d 4144 to 4300 34 to 190   AAA Submitted on the opposite strand 157/190
(82 %)
7 diff
(96.4 %id)
AI270147 ovary, papillary serous carcinoma .d 4144 to 4298 11 to 166   AAA Submitted on the opposite strand 156/168
(92 %)
8 diff
(95.3 %id)
AI334844 breast, breast carcinoma in situ .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI306758 breast, breast carcinoma in situ .d 4144 to 4329 34 to 217     Submitted on the opposite strand 184/225
(81 %)
16 diff
(92.9 %id)
AI305365 breast, breast carcinoma in situ .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI305463 breast, breast carcinoma in situ .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI271582 breast, normal epithelium .d 4144 to 4298 13 to 167   AAA Submitted on the opposite strand 155/169
(91 %)
7 diff
(95.9 %id)
AI334672 breast, normal epithelium .d 4144 to 4299 11 to 166   AAA Submitted on the opposite strand 156/167
(93 %)
7 diff
(95.9 %id)
AI334751 breast, normal epithelium .d 4144 to 4298 11 to 165   AAA Submitted on the opposite strand 155/167
(92 %)
7 diff
(95.9 %id)
AI250375 borderline ovarian carcinoma, ovary .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/168
(94 %)
7 diff
(95.9 %id)
AI223489 borderline ovarian carcinoma, ovary .d 4144 to 4299 11 to 166   AAA Submitted on the opposite strand 156/166
(93 %)
7 diff
(95.8 %id)
AI223515 borderline ovarian carcinoma, ovary .d 4144 to 4329 11 to 194     Submitted on the opposite strand 184/202
(91 %)
26 diff
(87.2 %id)
AI223676 borderline ovarian carcinoma, ovary .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/168
(93 %)
7 diff
(95.9 %id)
AI223706 borderline ovarian carcinoma, ovary .d 4144 to 4305 11 to 172   AAA Submitted on the opposite strand 162/172
(94 %)
7 diff
(96.0 %id)
AI250081 borderline ovarian carcinoma, ovary .d 4144 to 4313 11 to 179     Submitted on the opposite strand 169/181
(93 %)
11 diff
(94.0 %id)
AI250225 borderline ovarian carcinoma, ovary .d 4144 to 4326 11 to 191     Submitted on the opposite strand 181/199
(90 %)
14 diff
(93.0 %id)
AI246833 borderline ovarian carcinoma, ovary .d 4144 to 4329 34 to 218     Submitted on the opposite strand 185/226
(81 %)
17 diff
(92.5 %id)
AI247150 borderline ovarian carcinoma, ovary .d 4144 to 4329 34 to 217     Submitted on the opposite strand 184/225
(81 %)
16 diff
(92.9 %id)
AI250139 borderline ovarian carcinoma, ovary .d 4144 to 4329 11 to 195     Submitted on the opposite strand 185/203
(91 %)
17 diff
(91.7 %id)
AI250965 borderline ovarian carcinoma, ovary .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/168
(94 %)
7 diff
(95.9 %id)
AI311861 bronchioalveolar carcinoma, lung .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
7 diff
(95.9 %id)
AI371553 bronchioalveolar carcinoma, lung .d 4144 to 4300 11 to 166   AAA Submitted on the opposite strand 156/166
(93 %)
7 diff
(95.8 %id)
AI349813 invasive adenocarcinoma, lung .d 4144 to 4298 12 to 166   AAA Submitted on the opposite strand 155/168
(92 %)
7 diff
(95.9 %id)
AI349959 invasive adenocarcinoma, lung .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI318253 early stage papillary serous carcinoma, ovary .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/168
(93 %)
7 diff
(95.9 %id)
AI310545 adenocarcinoma, breast .d 4144 to 4324 11 to 189     Submitted on the opposite strand 179/198
(90 %)
14 diff
(93.0 %id)
AI310540 adenocarcinoma, breast .d 4144 to 4329 22 to 206     Submitted on the opposite strand 185/214
(86 %)
15 diff
(93.0 %id)
AI340878 adenocarcinoma, breast .d 4144 to 4329 11 to 194     Submitted on the opposite strand 184/200
(92 %)
16 diff
(92.0 %id)
AI340772 adenocarcinoma, breast .d 4144 to 4305 11 to 171   AAA Submitted on the opposite strand 161/171
(94 %)
7 diff
(96.0 %id)
AI349669 adenocarcinoma, breast .d 4144 to 4303 11 to 171   AAA Submitted on the opposite strand 161/173
(93 %)
9 diff
(94.8 %id)
AI349931 brain, oligodendroglioma .d 4144 to 4319 11 to 184     Submitted on the opposite strand 174/192
(90 %)
11 diff
(94.3 %id)
AI371599 brain, oligodendroglioma .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/168
(94 %)
7 diff
(95.9 %id)
AI345337 invasive adenocarcinoma, lung .d 4144 to 4693 11 to 561     Submitted on the opposite strand 551/561
(98 %)
8 diff
(98.6 %id)
AI345603 invasive adenocarcinoma, lung .d 4144 to 4314 11 to 181   AAA Submitted on the opposite strand 171/181
(94 %)
6 diff
(96.7 %id)
AI343992 bronchioalveolar carcinoma, lung .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/169
(93 %)
8 diff
(95.3 %id)
AI344077 bronchioalveolar carcinoma, lung .d 4144 to 4300 11 to 168   AAA Submitted on the opposite strand 158/169
(93 %)
8 diff
(95.3 %id)
AI344084 bronchioalveolar carcinoma, lung .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
AI343193 bronchioalveolar carcinoma, lung .d 4144 to 4329 11 to 195     Submitted on the opposite strand 185/203
(91 %)
18 diff
(91.2 %id)
AI611593 bone marrow, CD34+, CD38- from normal bone marrow donor .d 4144 to 4305 22 to 183   AAA Submitted on the opposite strand 162/183
(88 %)
6 diff
(96.8 %id)
AI583875 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .d 4144 to 4300 22 to 178   AAA Submitted on the opposite strand 157/178
(88 %)
6 diff
(96.7 %id)
AI591249 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .d 4144 to 4326 11 to 191     Submitted on the opposite strand 181/200
(90 %)
14 diff
(93.0 %id)
AI591250 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .d 4144 to 4300 34 to 190   AAA Submitted on the opposite strand 157/190
(82 %)
6 diff
(96.9 %id)
AW086250 pooled .d 4144 to 4300 19 to 175   AAA Submitted on the opposite strand 157/175
(89 %)
6 diff
(96.6 %id)
AW086311 pooled .d 4144 to 4305 19 to 180   AAA Submitted on the opposite strand 162/180
(90 %)
6 diff
(96.7 %id)
AW086327 pooled .d 4144 to 4322 19 to 196     Submitted on the opposite strand 178/216
(82 %)
13 diff
(94.0 %id)
AW271887 ovary, papillary serous carcinoma .d 4144 to 4222 11 to 88     Submitted on the opposite strand 78/88
(88 %)
6 diff
(93.2 %id)
AW271103 ovary, papillary serous carcinoma .d 4144 to 4204 11 to 71     Submitted on the opposite strand 61/71
(85 %)
6 diff
(91.6 %id)
AW271108 ovary, papillary serous carcinoma .d 4144 to 4305 11 to 173   AAA Submitted on the opposite strand 163/173
(94 %)
7 diff
(96.0 %id)
AW271121 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
7 diff
(95.9 %id)
AW271129 ovary, papillary serous carcinoma .d 4144 to 4299 11 to 166   AAA Submitted on the opposite strand 156/167
(93 %)
8 diff
(95.3 %id)
AW301905 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
BE138921 ovary, papillary serous carcinoma .d 4144 to 4298 40 to 194     Submitted on the opposite strand 155/196
(79 %)
7 diff
(96.5 %id)
BE138929 ovary, papillary serous carcinoma .d 4144 to 4300 40 to 196   AAA Submitted on the opposite strand 157/196
(80 %)
7 diff
(96.5 %id)
BE139298 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
BE139396 ovary, papillary serous carcinoma .d 4144 to 4302 11 to 169   AAA Submitted on the opposite strand 159/169
(94 %)
6 diff
(96.5 %id)
BE139690 ovary, papillary serous carcinoma .d 4144 to 4302 40 to 198   AAA Submitted on the opposite strand 159/198
(80 %)
6 diff
(97.0 %id)
BE138413 ovary, papillary serous carcinoma .d 4144 to 4300 11 to 167   AAA Submitted on the opposite strand 157/167
(94 %)
6 diff
(96.5 %id)
BE138430 ovary, papillary serous carcinoma .d 4144 to 4298 11 to 165   AAA Submitted on the opposite strand 155/167
(92 %)
7 diff
(95.9 %id)
BE138487 ovary, papillary serous carcinoma .d 4144 to 4300 41 to 198   AAA Submitted on the opposite strand 158/198
(79 %)
7 diff
(96.5 %id)
AW301885 invasive adenocarcinoma, lung .d 4144 to 4204 11 to 71     Submitted on the opposite strand 61/71
(85 %)
6 diff
(91.6 %id)
AW274325 invasive adenocarcinoma, lung .d 4144 to 4204 11 to 71     Submitted on the opposite strand 61/71
(85 %)
6 diff
(91.6 %id)
BE041232 borderline ovarian carcinoma, ovary .d 4144 to 4310 40 to 205       166/206
(80 %)
10 diff
(95.2 %id)
BE857850 ovary, papillary serous carcinoma .d 4144 to 4300 22 to 179   AAA   158/179
(88 %)
7 diff
(96.1 %id)
BE857848 ovary, papillary serous carcinoma .d 4144 to 4300 22 to 179   AAA   158/179
(88 %)
7 diff
(96.1 %id)
BE857796 ovary, papillary serous carcinoma .d 4144 to 4204 11 to 71       61/71
(85 %)
6 diff
(91.6 %id)
BE857888 ovary, papillary serous carcinoma .d 4144 to 4300 22 to 178   AAA   157/178
(88 %)
6 diff
(96.7 %id)
BE857927 ovary, papillary serous carcinoma .d 4144 to 4300 22 to 178   AAA   157/178
(88 %)
6 diff
(96.7 %id)
BM984408 lung, Primary Lung Epithelial Cells .d 4144 to 4302 19 to 178   AAA Submitted on the opposite strand 160/160
(100 %)
5 diff
(96.9 %id)
BE042245 borderline ovarian carcinoma, ovary .d 4145 to 4223 1 to 79       79/104
(75 %)
1 diff
(99.1 %id)
CA313572 Human Lung Epithelial cells, lung .d 4145 to 4302 20 to 178   AAA Submitted on the opposite strand 159/161
(98 %)
6 diff
(96.3 %id)
AI284906 breast, invasive carcinoma .d 4146 to 4215 1 to 70       70/70
(100 %)
1 diff
(98.6 %id)
BE042148 borderline ovarian carcinoma, ovary .d 4146 to 4223 1 to 78       78/109
(71 %)
1 diff
(99.1 %id)
BE042268 borderline ovarian carcinoma, ovary .d 4146 to 4316 1 to 170       170/170
(100 %)
7 diff
(95.9 %id)
BF054716 brain, oligodendroglioma .d 4146 to 4223 1 to 78       78/100
(78 %)
3 diff
(97.0 %id)
BM841181 myeloma .d 4149 to 4557 1 to 407       407/407
(100 %)
6 diff
(98.6 %id)
AI525667 Prostate .d 4150 to 4715 27 to 586       558/830
(67 %)
33 diff
(96.1 %id)
BU686847 lung, Primary Lung Epithelial Cells .d 4150 to 4766 19 to 635     Submitted on the opposite strand 617/617
(100 %)
1 diff
(99.9 %id)
BE041916 borderline ovarian carcinoma, ovary .d 4151 to 4223 1 to 73       73/100
(73 %)
1 diff
(99.0 %id)
BF058011 brain, oligodendroglioma .d 4151 to 4250 1 to 100       100/108
(92 %)
4 diff
(96.3 %id)
AW268094 ovary, papillary serous carcinoma .d 4152 to 4300 1 to 149   AAA Submitted on the opposite strand 149/149
(100 %)
0 diff
(100 %id)
BG576784 breast, mammary adenocarcinoma, cell line .d 4174 to 4783 1 to 614       614/819
(74 %)
10 diff
(98.8 %id)
BG955961 colon .d 4184 to 4467 1 to 285       285/285
(100 %)
8 diff
(97.2 %id)
BF926663 nervous_tumor .d 4199 to 4512 13 to 328       314/328
(95 %)
8 diff
(97.6 %id)
BU193744 melanotic melanoma, skin .d 4221 to 4866 1 to 649       649/895
(72 %)
8 diff
(99.2 %id)
BM696218 eye, human retina .d 4223 to 4400 2 to 179   fully sequenced, Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 178/179
(99 %)
0 diff
(100 %id)
BQ021680 lung, Metastatic Chondrosarcoma .d 4253 to 4846 612 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 594/599
(99 %)
1 diff
(99.9 %id)
CA426852 cell lines, Chondrosarcoma .d 4267 to 4853 605 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
BQ182493 Knee, Osteoarthritic Cartilage .d 4288 to 4851 583 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 565/565
(100 %)
2 diff
(99.7 %id)
TI_159722081   .d 4300 to 4856 77 to 634     Submitted on the opposite strand 558/1066
(52 %)
9 diff
(99.2 %id)
BU607818 Human Lung Epithelial cells, lung .d 4300 to 4547 33 to 280     Submitted on the opposite strand 248/274
(90 %)
12 diff
(95.7 %id)
CA944446 Human Lung Epithelial cells, lung .d 4300 to 4856 36 to 593     Submitted on the opposite strand 558/608
(91 %)
9 diff
(98.6 %id)
BQ021122 lung, Metastatic Chondrosarcoma .d 4305 to 4846 560 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 542/542
(100 %)
1 diff
(99.9 %id)
CN425520 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 4306 to 4601 1 to 296       296/296
(100 %)
0 diff
(100 %id)
BX424546 neuroblastoma .d 4328 to 4869 1 to 542   tiling clone,   542/542
(100 %)
0 diff
(100 %id)
BX425660 neuroblastoma .d 4328 to 4866 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BM664489 eye, human retina .d 4339 to 4867 547 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
CA420198 Bone, Human Chondrosarcoma Cell Line .d 4355 to 4860 524 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 506/506
(100 %)
4 diff
(99.3 %id)
NM_000356.3   .e 1 to 4864 1 to 4864 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4864/4864
(100 %)
0 diff
(100 %id)
U76366   .e 34 to 4849 1 to 4816 A588P V810A tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4816/4816
(100 %)
8 diff
(99.9 %id)
NM_001008657.2   .f 1 to 3860 1 to 3860 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3860/3860
(100 %)
0 diff
(100 %id)
BC011764 Skin, melanotic melanoma. .f 80 to 3478 1 to 3399 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3399/3399
(100 %)
0 diff
(100 %id)
BC014559 Skin, melanotic melanoma. .f 80 to 3478 1 to 3399   available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3399/3399
(100 %)
0 diff
(100 %id)
BC033093 Skin, melanotic melanoma. .f 80 to 3478 1 to 3399   available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3399/3399
(100 %)
0 diff
(100 %id)
BU619131 Cell Line, Chondrosarcoma .f 2882 to 3481 618 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 600/600
(100 %)
1 diff
(99.9 %id)
AK296918 tongue, tumor tissue .g 1 to 2663 6 to 1689 N109M S110G S111M V112G L113P ... tiling clone, Suspected internal deletion 1689/1689
(100 %)
4 diff
(99.8 %id)
AB209317 brain .h 1 to 5195 1 to 5195 exact tiling clone,   5195/5195
(100 %)
1 diff
(100.0 %id)
BF766068 colon_est .h 3557 to 3700 144 to 1     Submitted on the opposite strand 144/144
(100 %)
1 diff
(99.4 %id)
DW465888 Liver .h 3711 to 4050 16 to 355       340/355
(95 %)
6 diff
(98.4 %id)
CB108909 Liver .h 4133 to 4643 1 to 512       512/512
(100 %)
4 diff
(99.3 %id)
AI597580 adenocarcinoma, Pancreas .h 4796 to 5200 405 to 1   tiling clone,   405/405
(100 %)
0 diff
(100 %id)
BX111587 germinal center B cell .i 1 to 766 1 to 766   tiling clone,   766/766
(100 %)
1 diff
(99.9 %id)
AA456894 germinal center B cell .i 1 to 430 1 to 428       428/428
(100 %)
2 diff
(99.6 %id)
AA457050 germinal center B cell .i 492 to 1083 590 to 1   tiling clone,   590/590
(100 %)
7 diff
(98.9 %id)
AW796642 uterus .i 1068 to 1225 167 to 10   tiling clone,   158/168
(94 %)
0 diff
(100 %id)
BX537490 human endometrium .j 1 to 5225 1 to 5228 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 5228/5228
(100 %)
6 diff
(99.9 %id)
CN426219 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 2633 to 3280 1 to 648   tiling clone,   648/648
(100 %)
5 diff
(99.3 %id)
DA646106 mammary gland .j 2813 to 3554 2 to 742   capped   741/741
(100 %)
1 diff
(99.9 %id)
BE749150 carcinoma cell line, cervix .j 2972 to 3736 22 to 797       776/923
(84 %)
27 diff
(97.1 %id)
CR982808 T-Lymphocytes .j 3138 to 3542 1 to 405       405/405
(100 %)
0 diff
(100 %id)
DB360740 mammary gland .j 3953 to 4451 499 to 1       499/551
(90 %)
2 diff
(99.7 %id)
BQ052066 blood, natural killer cells, cell line .k 1 to 976 1 to 979   tiling clone,   979/1057
(92 %)
23 diff
(97.9 %id)
DB194010 ovary, tumor tissue .k 161 to 714 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BQ712740 Spleen .k 896 to 1794 1 to 925   tiling clone,   925/927
(99 %)
42 diff
(95.5 %id)
BI053290 placenta_normal .l 1 to 314 328 to 18   tiling clone,   311/328
(94 %)
0 diff
(100 %id)
CR991578 T-Lymphocytes .l 284 to 1157 1 to 874   tiling clone,   874/874
(100 %)
4 diff
(99.6 %id)
AA976800 pooled germ cell tumors .m 1 to 525 525 to 1   tiling clone,   525/525
(100 %)
3 diff
(99.5 %id)
AA399006   .m 52 to 620 1 to 570   tiling clone, fully sequenced,   570/570
(100 %)
2 diff
(99.7 %id)
AA399645   .m 573 to 1076 505 to 3   tiling clone, fully sequenced,   503/505
(99 %)
0 diff
(100 %id)
CB306505 lung, Primary Lung Cystic Fibrosis EpithelialCells .m 815 to 1492 12 to 689     Submitted on the opposite strand 678/689
(98 %)
6 diff
(99.2 %id)
BU626551 Alveolar Macrophage, lung .m 815 to 1528 12 to 726   tiling clone, Submitted on the opposite strand 715/726
(98 %)
6 diff
(99.2 %id)
AI765758 2 pooled tumors (clear cell type), Kidney .m 819 to 1298 1 to 480     Submitted on the opposite strand 480/480
(100 %)
1 diff
(99.8 %id)
BF360107 marrow .m 1342 to 1521 1 to 179       179/194
(92 %)
6 diff
(97.0 %id)
BX503419 Liver .n-u 1 to 544 24 to 567 exact tiling clone,   544/567
(95 %)
6 diff
(99.0 %id)
DA699548   .o 1 to 525 2 to 526   tiling clone, capped   525/525
(100 %)
0 diff
(100 %id)
BM450738 eye, retinoblastoma .o 280 to 1232 1 to 961   tiling clone,   961/984
(97 %)
26 diff
(97.4 %id)
BE764100 nervous_tumor .p-u 1 to 632 643 to 12   tiling clone,   632/643
(98 %)
0 diff
(100 %id)
TI_154088864   .p-u 129 to 664 652 to 117   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 536/537
(99 %)
1 diff
(99.9 %id)
BX099586 brain, glioblastoma (pooled) .p-u 181 to 683 1 to 503   tiling clone,   503/503
(100 %)
2 diff
(99.7 %id)
AA829361 colon, colon tumor .p-u 475 to 668 203 to 9       195/203
(96 %)
0 diff
(100 %id)
AI939467 brain, glioblastoma (pooled) .p-u 499 to 1043 545 to 1 exact tiling clone,   545/545
(100 %)
1 diff
(99.9 %id)
FN088168 breast carcinoma .p-u 567 to 658 88 to 1     Submitted on the opposite strand 88/90
(97 %)
4 diff
(95.6 %id)
AI419459 brain, glioblastoma (pooled) .p-u 669 to 1043 375 to 1 exact tiling clone,   375/375
(100 %)
0 diff
(100 %id)
AW135418   .p-u 719 to 1043 342 to 18 S16C P18R P20L P29H L38M ... AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 325/325
(100 %)
9 diff
(97.3 %id)
CV426438 amnion_normal .q-u 1 to 324 370 to 47   tiling clone, Submitted on the opposite strand 324/370
(87 %)
0 diff
(100 %id)
BF090317 nervous_normal .q-u 217 to 381 165 to 1       165/165
(100 %)
1 diff
(99.4 %id)
BE465033 carcinoid, lung .q-u 303 to 763 480 to 20 C9W L45X G48X E49K G51X ... AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 461/461
(100 %)
7 diff
(98.5 %id)
CN479461 Chondrosarcoma, Left Pubic Bone .q-u 304 to 764 479 to 19 L3X tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 461/534
(86 %)
3 diff
(99.5 %id)
AI570584 anaplastic oligodendroglioma, brain .q-u 305 to 768 464 to 1 K16N L45X S50X G51X P52X     464/464
(100 %)
5 diff
(99.0 %id)
AI719465 colon .q-u 328 to 778 455 to 4       452/472
(95 %)
0 diff
(100 %id)
BU181935 eye, retinoblastoma .q-u 347 to 755 1 to 409   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
AA580140 breast .q-u 348 to 758 441 to 32   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 410/410
(100 %)
1 diff
(99.8 %id)
Z20729   .q-u 353 to 451 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
BE348736 carcinoid, lung .q-u 407 to 763 377 to 20   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 358/358
(100 %)
8 diff
(97.8 %id)
AA343053 Spleen .q-u 413 to 694 282 to 1       282/282
(100 %)
1 diff
(99.7 %id)
AI086146 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 418 to 768 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AV722768 hypothalamus .q-u 430 to 768 82 to 420       339/462
(73 %)
12 diff
(97.5 %id)
AW304482 pooled .q-u 466 to 768 305 to 1       305/558
(54 %)
3 diff
(99.5 %id)
TI_154167987   .q-u 469 to 765 378 to 82     Submitted on the opposite strand 297/301
(98 %)
0 diff
(100 %id)
AW341030 carcinoid, lung .q-u 478 to 768 293 to 3       291/293
(99 %)
0 diff
(100 %id)
CF138180 lymph .q-u 480 to 765 295 to 10     Submitted on the opposite strand 286/295
(96 %)
0 diff
(100 %id)
AI457866 carcinoid, lung .q-u 483 to 765 283 to 1       283/284
(99 %)
0 diff
(100 %id)
AI304411 adenocarcinoma, colon .q-u 486 to 772 287 to 1       287/287
(100 %)
1 diff
(99.7 %id)
AA988028 carcinoid, lung .q-u 497 to 768 274 to 3       272/274
(99 %)
0 diff
(100 %id)
AW612062 carcinoid, lung .q-u 507 to 768 264 to 3       262/265
(98 %)
0 diff
(100 %id)
EC522267 Prostate .q-u 535 to 645 1 to 109       109/109
(100 %)
4 diff
(96.4 %id)
AA504058 Prostate .q-u 550 to 779 8 to 237   tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 230/237
(97 %)
6 diff
(97.5 %id)
AI474683 Kidney .q-u 551 to 766 216 to 1       216/216
(100 %)
0 diff
(100 %id)
BG271352 normal head/neck tissue .q-u 570 to 737 168 to 1       168/195
(86 %)
0 diff
(100 %id)
DN604339   .q-u 571 to 768 1 to 200       200/224
(89 %)
4 diff
(98.3 %id)
AI034160 parathyroid gland, parathyroid tumor .q-u 601 to 780 197 to 19       179/197
(90 %)
0 diff
(100 %id)
AW001182 colon, colonic mucosa from 3 patients with Crohn'sdisease .q-u 660 to 761 115 to 14   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 102/102
(100 %)
0 diff
(100 %id)
AW365626 head_neck .r-u 1 to 518 1 to 518 exact tiling clone,   518/526
(98 %)
12 diff
(97.8 %id)
BF351554 head_neck .r-u 3 to 123 141 to 22   tiling clone,   120/141
(85 %)
0 diff
(100 %id)
BF869665 lung_tumor .r-u 10 to 324 322 to 8   tiling clone, Submitted on the opposite strand 315/323
(97 %)
0 diff
(100 %id)
AK096467 brain Gene TCOF1, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AK225284 Liver Gene TCOF1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CN426218 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene TCOF1, variant not shown         Suspected internal deletion, this clone was ignored    
DC347446 tongue, tumor tissue Gene TCOF1, variant not shown         Suspected internal deletion, this clone was ignored    
AI053622 ovary, papillary serous carcinoma Gene TCOF1, variant not shown         This clone was ignored    
AI203103 pooled germ cell tumors Gene TCOF1, variant not shown         This clone was ignored    
AI968648 pooled germ cell tumors Gene TCOF1, variant not shown         This clone was ignored    
BE672373 pooled germ cell tumors Gene TCOF1, variant not shown         This clone was ignored    
BE279493 choriocarcinoma, placenta Gene TCOF1, variant not shown         Suspected internal deletion, this clone was ignored    
BE798834 lung, small cell carcinoma Gene TCOF1, variant not shown         Suspected internal deletion, this clone was ignored    
BI860628 breast, mammary adenocarcinoma, cell line Gene TCOF1, variant not shown         This clone was ignored    
U40847   Gene TCOF1, variant not shown       AAA Suspected internal deletion, suspected internal deletion, suspected internal deletion, suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p-u, .q-u, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI